STRATEGY STUDIO / NONPROFIT PEOPLE SEARCH

CANCER RESEARCH AMERICA NFCR INC: Form 990, tax year 2023

View the entire original 990 at ProPublica ↗

Organization
CANCER RESEARCH AMERICA NFCR INC (EIN 04-2531031)
Tax period
2023-01-01 to 2023-12-31
Filed
2024-09-05
IRS object ID
202402499349301650
Schema version
2023v5.1
Source
Download XML · Original 990 at ProPublica

Every field in the e-filed return. Faint text is the IRS element name, for citing.

Return header ReturnHeader

FieldValueIRS element (for citing)
Return2024-09-05T12:27:06-05:00ReturnTs
Tax Period End2023-12-31TaxPeriodEndDt

Preparer Firm PreparerFirmGrp

Preparer Firm Name PreparerFirmName

FieldValueIRS element (for citing)
Business Name Line1WITHUMSMITHBROWNPCBusinessNameLine1Txt

Preparer US Address PreparerUSAddress

FieldValueIRS element (for citing)
Address Line14600 EAST WEST HWY 900AddressLine1Txt
CityBETHESDACityNm
State AbbreviationMDStateAbbreviationCd
ZIP208143423ZIPCd
FieldValueIRS element (for citing)
Return Type990ReturnTypeCd
Tax Period Begin2023-01-01TaxPeriodBeginDt

Filer Filer

FieldValueIRS element (for citing)
EIN042531031EIN

Business Name BusinessName

FieldValueIRS element (for citing)
Business Name Line1NATIONAL FOUNDATION FOR CANCER RESEARCHBusinessNameLine1Txt
FieldValueIRS element (for citing)
In Care Of% KWOK LEUNGInCareOfNm
Business Name ControlNATIBusinessNameControlTxt
Phone3016541250PhoneNum

US Address USAddress

FieldValueIRS element (for citing)
Address Line15515 SECURITY LANE Suite 1105AddressLine1Txt
CityROCKVILLECityNm
State AbbreviationMDStateAbbreviationCd
ZIP20852ZIPCd

Business Officer BusinessOfficerGrp

FieldValueIRS element (for citing)
PersonSUJUAN BAPersonNm
Person TitlePRESIDENT & CEOPersonTitleTxt
Phone3016541250PhoneNum
Signature2024-09-04SignatureDt
Discuss With Paid PreparerYes (true)DiscussWithPaidPreparerInd
FieldValueIRS element (for citing)
IRS Responsible Prty Info CurrYes (true)IRSResponsiblePrtyInfoCurrInd

Preparer Person PreparerPersonGrp

FieldValueIRS element (for citing)
Preparer PersonRICHARD RUVELSONPreparerPersonNm
PTINP00234075PTIN
Phone3012726000PhoneNum
FieldValueIRS element (for citing)
Tax2023TaxYr
Build TS2024-08-08 14:25:15ZBuildTS

Form 990 IRS990

FieldValueIRS element (for citing)
Principal OfficerSUJUAN BAPrincipalOfficerNm

US Address USAddress

FieldValueIRS element (for citing)
Address Line15515 SECURITY LANE SUITE 1105AddressLine1Txt
CityROCKVILLECityNm
State AbbreviationMDStateAbbreviationCd
ZIP20852ZIPCd
FieldValueIRS element (for citing)
Gross Receipts$9,866,139GrossReceiptsAmt
Group Return For AffiliatesfalseGroupReturnForAffiliatesInd
Group Exemption5582GroupExemptionNum
Organization501c3Yes (X)Organization501c3Ind
Website AddressWWW.NFCR.ORGWebsiteAddressTxt
Type Of Organization CorpYes (X)TypeOfOrganizationCorpInd
Formation1973FormationYr
Legal Domicile StateMALegalDomicileStateCd
Activity Or MissionTO SUPPORT CANCER RESEARCH AND PUBLIC EDUCATION RELATING TO PREVENTION, EARLIER DIAGNOSIS, BETTER TREATMENTS AND ULTIMATELY, A CURE FOR CANCER.ActivityOrMissionDesc
Voting Members Governing Body5VotingMembersGoverningBodyCnt
Voting Members Independent5VotingMembersIndependentCnt
Total Employee16TotalEmployeeCnt
Total Volunteers5TotalVolunteersCnt
Total Gross UBI$0TotalGrossUBIAmt
Net Unrelated Bus Txbl Incm$0NetUnrelatedBusTxblIncmAmt
PY Contributions Grants$8,181,991PYContributionsGrantsAmt
CY Contributions Grants$8,681,414CYContributionsGrantsAmt
PY Program Service Revenue$0PYProgramServiceRevenueAmt
CY Program Service Revenue$0CYProgramServiceRevenueAmt
PY Investment Income$138,215PYInvestmentIncomeAmt
CY Investment Income$370,595CYInvestmentIncomeAmt
PY Other Revenue$87,853PYOtherRevenueAmt
CY Other Revenue$110,433CYOtherRevenueAmt
PY Total Revenue$8,408,059PYTotalRevenueAmt
CY Total Revenue$9,162,442CYTotalRevenueAmt
PY Grants And Similar Paid$2,285,179PYGrantsAndSimilarPaidAmt
CY Grants And Similar Paid$3,445,964CYGrantsAndSimilarPaidAmt
PY Benefits Paid To Members$0PYBenefitsPaidToMembersAmt
CY Benefits Paid To Members$0CYBenefitsPaidToMembersAmt
PY Salaries Comp Emp Bnft Paid$2,194,753PYSalariesCompEmpBnftPaidAmt
CY Salaries Comp Emp Bnft Paid$1,910,593CYSalariesCompEmpBnftPaidAmt
PY Total Prof Fndrsng Expns$31,557PYTotalProfFndrsngExpnsAmt
CY Total Prof Fndrsng Expns$31,582CYTotalProfFndrsngExpnsAmt
CY Total Fundraising Expense$1,766,659CYTotalFundraisingExpenseAmt
PY Other Expenses$3,973,419PYOtherExpensesAmt
CY Other Expenses$4,402,392CYOtherExpensesAmt
PY Total Expenses$8,484,908PYTotalExpensesAmt
CY Total Expenses$9,790,531CYTotalExpensesAmt
PY Revenues Less Expenses-$76,849PYRevenuesLessExpensesAmt
CY Revenues Less Expenses-$628,089CYRevenuesLessExpensesAmt
Total Assets BOY$10,719,078TotalAssetsBOYAmt
Total Assets EOY$10,533,674TotalAssetsEOYAmt
Total Liabilities BOY$3,111,496TotalLiabilitiesBOYAmt
Total Liabilities EOY$2,852,963TotalLiabilitiesEOYAmt
Net Assets Or Fund Balances BOY$7,607,582NetAssetsOrFundBalancesBOYAmt
Net Assets Or Fund Balances EOY$7,680,711NetAssetsOrFundBalancesEOYAmt
Info In Schedule O Part IIIYes (X)InfoInScheduleOPartIIIInd
MissionSEE SCHEDULE OMissionDesc
Significant New Program SrvcfalseSignificantNewProgramSrvcInd
Significant ChangefalseSignificantChangeInd
Expense$4,781,528ExpenseAmt
Grant$3,445,964GrantAmt
DescCANCER RESEARCH - SEE SCHEDULE ODesc

Prog Srvc Accom Acty2 ProgSrvcAccomActy2Grp

FieldValueIRS element (for citing)
Expense$2,400,565ExpenseAmt
DescCANCER PREVENTION EDUCATION TO THE PUBLIC - SEE SCHEDULE ODesc
FieldValueIRS element (for citing)
Total Program Service Expenses$7,182,093TotalProgramServiceExpensesAmt
Described In Section501c3Yes (true)DescribedInSection501c3Ind
Schedule B RequiredYes (true)ScheduleBRequiredInd
Political Campaign ActyfalsePoliticalCampaignActyInd
Lobbying ActivitiesfalseLobbyingActivitiesInd
Subject To Proxy TaxfalseSubjectToProxyTaxInd
Donor Advised FundYes (true)DonorAdvisedFundInd
Conservation EasementsfalseConservationEasementsInd
Collections Of ArtfalseCollectionsOfArtInd
Credit CounselingfalseCreditCounselingInd
Donor Rstr Or Quasi EndowmentsYes (true)DonorRstrOrQuasiEndowmentsInd
Report Land Building EquipmentYes (true)ReportLandBuildingEquipmentInd
Report Investments Other SecfalseReportInvestmentsOtherSecInd
Report Program Related InvstfalseReportProgramRelatedInvstInd
Report Other AssetsYes (true)ReportOtherAssetsInd
Report Other LiabilitiesYes (true)ReportOtherLiabilitiesInd
Include FIN48 FootnoteYes (true)IncludeFIN48FootnoteInd
Independent Audit Fincl StmtfalseIndependentAuditFinclStmtInd
Consolidated Audit Fincl StmtYes (true)ConsolidatedAuditFinclStmtInd
School OperatingfalseSchoolOperatingInd
Foreign OfficefalseForeignOfficeInd
Foreign ActivitiesYes (true)ForeignActivitiesInd
More Than5000 K To OrgYes (true)MoreThan5000KToOrgInd
More Than5000 K To IndividualsYes (true)MoreThan5000KToIndividualsInd
Professional FundraisingYes (true)ProfessionalFundraisingInd
Fundraising ActivitiesYes (true)FundraisingActivitiesInd
Gaming ActivitiesfalseGamingActivitiesInd
Operate HospitalfalseOperateHospitalInd
Grants To OrganizationsYes (true)GrantsToOrganizationsInd
Grants To IndividualsYes (true)GrantsToIndividualsInd
Schedule J RequiredYes (true)ScheduleJRequiredInd
Tax Exempt BondsfalseTaxExemptBondsInd
Engaged In Excess Benefit TransfalseEngagedInExcessBenefitTransInd
PY Excess Benefit TransfalsePYExcessBenefitTransInd
Loan OutstandingfalseLoanOutstandingInd
Grant To Related PersonfalseGrantToRelatedPersonInd
Business Rln With Org MemfalseBusinessRlnWithOrgMemInd
Business Rln With Fam MemfalseBusinessRlnWithFamMemInd
Business Rln With35 Ctrl EntfalseBusinessRlnWith35CtrlEntInd
Deductible Non Cash ContrifalseDeductibleNonCashContriInd
Deductible Art ContributionfalseDeductibleArtContributionInd
Terminate OperationsfalseTerminateOperationsInd
Partial LiquidationfalsePartialLiquidationInd
Disregarded EntityfalseDisregardedEntityInd
Related EntityYes (true)RelatedEntityInd
Related Organization Ctrl EntYes (true)RelatedOrganizationCtrlEntInd
Transaction With Control EntfalseTransactionWithControlEntInd
Trnsfr Exmpt Non Chrtbl Rltd OrgfalseTrnsfrExmptNonChrtblRltdOrgInd
Activities Conducted PrtshpfalseActivitiesConductedPrtshpInd
Schedule O RequiredYes (true)ScheduleORequiredInd
IRP Document23IRPDocumentCnt
IRP Document W2 G0IRPDocumentW2GCnt
Backup Wthld ComplianceYes (true)BackupWthldComplianceInd
Employee16EmployeeCnt
Employment Tax Returns FiledYes (true)EmploymentTaxReturnsFiledInd
Unrelated Bus Incm Over LimitfalseUnrelatedBusIncmOverLimitInd
Foreign Financial AccountfalseForeignFinancialAccountInd
Prohibited Tax Shelter TransfalseProhibitedTaxShelterTransInd
Taxable Party NotificationfalseTaxablePartyNotificationInd
Nondeductible ContributionsfalseNondeductibleContributionsInd
Quid Pro Quo ContributionsYes (true)QuidProQuoContributionsInd
Quid Pro Quo Contri DisclYes (true)QuidProQuoContriDisclInd
Form8282 Property Disposed OffalseForm8282PropertyDisposedOfInd
Rcv Fnds To Pay Prsnl Bnft CntrctfalseRcvFndsToPayPrsnlBnftCntrctInd
Pay Premiums Prsnl Bnft CntrctfalsePayPremiumsPrsnlBnftCntrctInd
DAF Excess Business HoldingsfalseDAFExcessBusinessHoldingsInd
Taxable DistributionsfalseTaxableDistributionsInd
Distribution To DonorfalseDistributionToDonorInd
Indoor Tanning ServicesfalseIndoorTanningServicesInd
Subj To Tax Rmnrtn Ex Prcht PymtfalseSubjToTaxRmnrtnExPrchtPymtInd
Subject To Excs Tax Net Invst IncfalseSubjectToExcsTaxNetInvstIncInd
Info In Schedule O Part VIYes (X)InfoInScheduleOPartVIInd
Governing Body Voting Members5GoverningBodyVotingMembersCnt
Independent Voting Member5IndependentVotingMemberCnt
Family Or Business RlnfalseFamilyOrBusinessRlnInd
Delegation Of Mgmt DutiesfalseDelegationOfMgmtDutiesInd
Change To Org DocumentsfalseChangeToOrgDocumentsInd
Material Diversion Or MisusefalseMaterialDiversionOrMisuseInd
Members Or StockholdersfalseMembersOrStockholdersInd
Election Of Board MembersfalseElectionOfBoardMembersInd
Decisions Subject To ApprovafalseDecisionsSubjectToApprovaInd
Minutes Of Governing BodyYes (true)MinutesOfGoverningBodyInd
Minutes Of CommitteesYes (true)MinutesOfCommitteesInd
Officer Mailing AddressfalseOfficerMailingAddressInd
Local ChaptersYes (true)LocalChaptersInd
Policies Reference ChaptersYes (true)PoliciesReferenceChaptersInd
Form990 Provided To Gvrn BodyYes (true)Form990ProvidedToGvrnBodyInd
Conflict Of Interest PolicyYes (true)ConflictOfInterestPolicyInd
Annual Disclosure Covered PrsnYes (true)AnnualDisclosureCoveredPrsnInd
Regular Monitoring EnfrcYes (true)RegularMonitoringEnfrcInd
Whistleblower PolicyYes (true)WhistleblowerPolicyInd
Document Retention PolicyYes (true)DocumentRetentionPolicyInd
Compensation Process CEOYes (true)CompensationProcessCEOInd
Compensation Process OtherYes (true)CompensationProcessOtherInd
Investment In Joint VenturefalseInvestmentInJointVentureInd
States Where Copy Of Return Is FldALStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldAKStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldAZStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldARStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldCAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldCOStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldCTStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldDCStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldFLStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldGAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldHIStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldILStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldINStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldKSStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldKYStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMEStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMDStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMIStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMNStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMSStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldNHStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldNJStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldNMStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldNYStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldNCStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldNDStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldOHStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldOKStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldORStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldPAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldRIStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldSCStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldTNStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldUTStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldVAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldWAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldWVStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldWIStatesWhereCopyOfReturnIsFldCd
Own WebsiteYes (X)OwnWebsiteInd
Upon RequestYes (X)UponRequestInd

Books In Care Of Detail BooksInCareOfDetail

FieldValueIRS element (for citing)
PersonKWOK LEUNGPersonNm
Phone3016541250PhoneNum

US Address USAddress

FieldValueIRS element (for citing)
Address Line15515 SECURITY LANE SUITE 1105AddressLine1Txt
CityROCKVILLECityNm
State AbbreviationMDStateAbbreviationCd
ZIP20852ZIPCd
FieldValueIRS element (for citing)
Info In Schedule O Part VIIYes (X)InfoInScheduleOPartVIIInd

Form990 Part VII Section A Form990PartVIISectionAGrp (10 entries)

TitleTitleTxtAverage Hours Per WeekAverageHoursPerWeekRtAverage Hours Per Week Rltd OrgAverageHoursPerWeekRltdOrgRtOfficerOfficerIndReportable Comp From OrgReportableCompFromOrgAmtReportable Comp From Rltd OrgReportableCompFromRltdOrgAmtOther CompensationOtherCompensationAmtHighest Compensated EmployeeHighestCompensatedEmployeeIndIndividual Trustee Or DirectorIndividualTrusteeOrDirectorInd
SUJUAN BA
PRESIDENT/CEO40.00.0Yes (X)$471,385$0$81,925
KWOK LEUNG
CFO/SECRETARY40.00.0Yes (X)$204,079$0$30,434
BRIAN WACHTEL
EXECUTIVE DIRECTOR40.00.0$151,108$0$17,381Yes (X)
ZETING WANG
SR. DIR OF DIRECT RESPONSE40.00.0$124,087$0$11,940Yes (X)
ALFRED SLANETZ
CHAIR OF THE BOARD5.00.0Yes (X)$0$0$0Yes (X)
BRIAN LEYLAND-JONES
TREASURER2.00.0Yes (X)$0$0$0Yes (X)
JUDITH P BARNHARD
DIRECTOR1.50.0$0$0$0Yes (X)
KAREN BURKE
DIRECTOR1.50.0$0$0$0Yes (X)
LANCE KAWAGUCHI
DIRECTOR1.00.0$0$0$0Yes (X)
Edward s west
Director (THRU 04/26/2023)1.00.0$0$0$0Yes (X)
FieldValueIRS element (for citing)
Total Reportable Comp From Org$950,659TotalReportableCompFromOrgAmt
Tot Reportable Comp Rltd Org$0TotReportableCompRltdOrgAmt
Total Other Compensation$141,680TotalOtherCompensationAmt
Indiv Rcvd Greater Than100 K4IndivRcvdGreaterThan100KCnt
Former Ofcr Employees ListedfalseFormerOfcrEmployeesListedInd
Total Comp Greater Than150 KYes (true)TotalCompGreaterThan150KInd
Compensation From Other SrcsfalseCompensationFromOtherSrcsInd

Contractor Compensation ContractorCompensationGrp (5 entries)

Address Line1ContractorAddress/USAddress/AddressLine1TxtCityContractorAddress/USAddress/CityNmState AbbreviationContractorAddress/USAddress/StateAbbreviationCdZIPContractorAddress/USAddress/ZIPCdServicesServicesDescCompensationCompensationAmt
AMERGENT INC
9 CENTENNIAL DRIVEPEABODYMA01960CONSULTING & MNGT$368,979
REDFIELD DIRECT LLC
11422 MIRACLE HILLS DR 450OMAHANE68154LABEL PRINTING$355,456
CENVEO WORLDWIDE LIMITED
ROUTE 866 PO DRAWER CWILLIAMBURGPA16693ENVELOPE PRINTING$322,521
CALMARK GROUP LLC
6755 SAYRE AVEBEDFORD PARKIL60638MAIL SHOP$322,350
LARSEN MARKETING GROUP
6236 WILMETTEBURKEVA22015CONSULTING$169,088
FieldValueIRS element (for citing)
Cntrct Rcvd Greater Than100 K7CntrctRcvdGreaterThan100KCnt
Federated Campaigns$43,437FederatedCampaignsAmt
Fundraising$289,157FundraisingAmt
All Other Contributions$8,348,820AllOtherContributionsAmt
Noncash Contributions$11,849NoncashContributionsAmt
Total Contributions$8,681,414TotalContributionsAmt
Total Program Service Revenue$0TotalProgramServiceRevenueAmt

Investment Income InvestmentIncomeGrp

FieldValueIRS element (for citing)
Total Revenue Column$246,067TotalRevenueColumnAmt
Exclusion$246,067ExclusionAmt

Incm From Invest Bond Proceeds IncmFromInvestBondProceedsGrp

FieldValueIRS element (for citing)
Total Revenue Column$0TotalRevenueColumnAmt

Royalties Revenue RoyaltiesRevenueGrp

FieldValueIRS element (for citing)
Total Revenue Column$6,870TotalRevenueColumnAmt
Exclusion$6,870ExclusionAmt

Rental Income Or Loss RentalIncomeOrLossGrp

FieldValueIRS element (for citing)
Real$0RealAmt
Personal$0PersonalAmt

Net Rental Income Or Loss NetRentalIncomeOrLossGrp

FieldValueIRS element (for citing)
Total Revenue Column$0TotalRevenueColumnAmt

Gross Amount Sales Assets GrossAmountSalesAssetsGrp

FieldValueIRS element (for citing)
Securities$783,438SecuritiesAmt

Less Cost Oth Basis Sales Expnss LessCostOthBasisSalesExpnssGrp

FieldValueIRS element (for citing)
Securities$658,910SecuritiesAmt

Gain Or Loss GainOrLossGrp

FieldValueIRS element (for citing)
Securities$124,528SecuritiesAmt

Net Gain Or Loss Investments NetGainOrLossInvestmentsGrp

FieldValueIRS element (for citing)
Total Revenue Column$124,528TotalRevenueColumnAmt
Exclusion$124,528ExclusionAmt
FieldValueIRS element (for citing)
Fundraising Gross Income$45,973FundraisingGrossIncomeAmt
Contri Rpt Fundraising Event$289,157ContriRptFundraisingEventAmt
Fundraising Direct Expenses$44,787FundraisingDirectExpensesAmt

Net Incm From Fundraising Evt NetIncmFromFundraisingEvtGrp

FieldValueIRS element (for citing)
Total Revenue Column$1,186TotalRevenueColumnAmt
Exclusion$1,186ExclusionAmt
FieldValueIRS element (for citing)
Gaming Gross Income$0GamingGrossIncomeAmt
Gaming Direct Expenses$0GamingDirectExpensesAmt

Net Income From Gaming NetIncomeFromGamingGrp

FieldValueIRS element (for citing)
Total Revenue Column$0TotalRevenueColumnAmt
FieldValueIRS element (for citing)
Gross Sales Of Inventory$0GrossSalesOfInventoryAmt
Cost Of Goods Sold$0CostOfGoodsSoldAmt

Net Income Or Loss NetIncomeOrLossGrp

FieldValueIRS element (for citing)
Total Revenue Column$0TotalRevenueColumnAmt

Other Revenue Misc OtherRevenueMiscGrp

FieldValueIRS element (for citing)
DescMAILING LIST RENTALSDesc
Business541800BusinessCd
Total Revenue Column$102,377TotalRevenueColumnAmt
Exclusion$102,377ExclusionAmt
FieldValueIRS element (for citing)
Other Revenue Total$102,377OtherRevenueTotalAmt

Total Revenue TotalRevenueGrp

FieldValueIRS element (for citing)
Total Revenue Column$9,162,442TotalRevenueColumnAmt
Exclusion$481,028ExclusionAmt

Grants To Domestic Orgs GrantsToDomesticOrgsGrp

FieldValueIRS element (for citing)
Total$3,116,805TotalAmt
Program Services$3,116,805ProgramServicesAmt

Grants To Domestic Individuals GrantsToDomesticIndividualsGrp

FieldValueIRS element (for citing)
Total$204,159TotalAmt
Program Services$204,159ProgramServicesAmt

Foreign Grants ForeignGrantsGrp

FieldValueIRS element (for citing)
Total$125,000TotalAmt
Program Services$125,000ProgramServicesAmt

Benefits To Members BenefitsToMembersGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Comp Current Ofcr Directors CompCurrentOfcrDirectorsGrp

FieldValueIRS element (for citing)
Total$791,882TotalAmt
Program Services$613,305ProgramServicesAmt
Management And General$173,028ManagementAndGeneralAmt
Fundraising$5,549FundraisingAmt

Comp Disqual Persons CompDisqualPersonsGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Other Salaries And Wages OtherSalariesAndWagesGrp

FieldValueIRS element (for citing)
Total$880,499TotalAmt
Program Services$596,421ProgramServicesAmt
Management And General$125,253ManagementAndGeneralAmt
Fundraising$158,825FundraisingAmt

Pension Plan Contributions PensionPlanContributionsGrp

FieldValueIRS element (for citing)
Total$82,727TotalAmt
Program Services$57,250ProgramServicesAmt
Management And General$8,040ManagementAndGeneralAmt
Fundraising$17,437FundraisingAmt

Other Employee Benefits OtherEmployeeBenefitsGrp

FieldValueIRS element (for citing)
Total$58,480TotalAmt
Program Services$38,997ProgramServicesAmt
Management And General$11,692ManagementAndGeneralAmt
Fundraising$7,791FundraisingAmt

Payroll Taxes PayrollTaxesGrp

FieldValueIRS element (for citing)
Total$97,005TotalAmt
Program Services$69,882ProgramServicesAmt
Management And General$17,013ManagementAndGeneralAmt
Fundraising$10,110FundraisingAmt

Fees For Services Management FeesForServicesManagementGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Fees For Services Legal FeesForServicesLegalGrp

FieldValueIRS element (for citing)
Total$39,329TotalAmt
Program Services$8,209ProgramServicesAmt
Management And General$31,120ManagementAndGeneralAmt

Fees For Services Accounting FeesForServicesAccountingGrp

FieldValueIRS element (for citing)
Total$53,151TotalAmt
Management And General$53,151ManagementAndGeneralAmt

Fees For Services Lobbying FeesForServicesLobbyingGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Fees For Services Prof Fundraising FeesForServicesProfFundraising

FieldValueIRS element (for citing)
Total$31,582TotalAmt
Fundraising$31,582FundraisingAmt

Fees For Srvc Invst Mgmnt Fees FeesForSrvcInvstMgmntFeesGrp

FieldValueIRS element (for citing)
Total$48,176TotalAmt
Management And General$48,176ManagementAndGeneralAmt

Fees For Services Other FeesForServicesOtherGrp

FieldValueIRS element (for citing)
Total$561,442TotalAmt
Program Services$236,044ProgramServicesAmt
Management And General$231,794ManagementAndGeneralAmt
Fundraising$93,604FundraisingAmt

Advertising AdvertisingGrp

FieldValueIRS element (for citing)
Total$34,926TotalAmt
Program Services$2,277ProgramServicesAmt
Management And General$12,219ManagementAndGeneralAmt
Fundraising$20,430FundraisingAmt

Office Expenses OfficeExpensesGrp

FieldValueIRS element (for citing)
Total$99,697TotalAmt
Program Services$30,388ProgramServicesAmt
Management And General$56,491ManagementAndGeneralAmt
Fundraising$12,818FundraisingAmt

Information Technology InformationTechnologyGrp

FieldValueIRS element (for citing)
Total$531,620TotalAmt
Program Services$306,464ProgramServicesAmt
Management And General$5,402ManagementAndGeneralAmt
Fundraising$219,754FundraisingAmt

Royalties RoyaltiesGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Occupancy OccupancyGrp

FieldValueIRS element (for citing)
Total$235,264TotalAmt
Program Services$169,328ProgramServicesAmt
Management And General$41,357ManagementAndGeneralAmt
Fundraising$24,579FundraisingAmt

Travel TravelGrp

FieldValueIRS element (for citing)
Total$69,688TotalAmt
Program Services$47,191ProgramServicesAmt
Management And General$20,596ManagementAndGeneralAmt
Fundraising$1,901FundraisingAmt

Pymt Travel Entrtnmnt Pub Ofcl PymtTravelEntrtnmntPubOfclGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Conferences Meetings ConferencesMeetingsGrp

FieldValueIRS element (for citing)
Total$93,018TotalAmt
Program Services$93,018ProgramServicesAmt

Interest InterestGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Payments To Affiliates PaymentsToAffiliatesGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Depreciation Depletion DepreciationDepletionGrp

FieldValueIRS element (for citing)
Total$8,876TotalAmt
Program Services$6,395ProgramServicesAmt
Management And General$1,558ManagementAndGeneralAmt
Fundraising$923FundraisingAmt

Insurance InsuranceGrp

FieldValueIRS element (for citing)
Total$24,117TotalAmt
Program Services$17,362ProgramServicesAmt
Management And General$4,239ManagementAndGeneralAmt
Fundraising$2,516FundraisingAmt

Other Expenses OtherExpensesGrp (4 entries)

DescDescTotalTotalAmtProgram ServicesProgramServicesAmtFundraisingFundraisingAmtManagement And GeneralManagementAndGeneralAmt
DIRECT MAIL PROGRAMS$2,494,465$1,379,960$1,114,505
LOCK BOX SERVICE$90,637$54,300$36,337
PROCESS FEES-LIST SALES$15,836$9,338$6,498
MISCELLANEOUS FUNDRAISING$2,150$1,500$650

Total Functional Expenses TotalFunctionalExpensesGrp

FieldValueIRS element (for citing)
Total$9,790,531TotalAmt
Program Services$7,182,093ProgramServicesAmt
Management And General$841,779ManagementAndGeneralAmt
Fundraising$1,766,659FundraisingAmt
FieldValueIRS element (for citing)
Joint CostsYes (X)JointCostsInd

Total Joint Costs TotalJointCostsGrp

FieldValueIRS element (for citing)
Total$2,879,259TotalAmt
Program Services$1,775,267ProgramServicesAmt
Fundraising$1,103,992FundraisingAmt

Cash Non Interest Bearing CashNonInterestBearingGrp

FieldValueIRS element (for citing)
BOY$1,162BOYAmt
EOY$1,337EOYAmt

Savings And Temp Cash Invst SavingsAndTempCashInvstGrp

FieldValueIRS element (for citing)
BOY$1,976,379BOYAmt
EOY$1,752,406EOYAmt

Pledges And Grants Receivable PledgesAndGrantsReceivableGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Accounts Receivable AccountsReceivableGrp

FieldValueIRS element (for citing)
BOY$58,323BOYAmt
EOY$51,727EOYAmt

Receivables From Officers Etc ReceivablesFromOfficersEtcGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Rcvbl From Disqualified Prsn RcvblFromDisqualifiedPrsnGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Oth Notes Loans Receivable Net OthNotesLoansReceivableNetGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Inventories For Sale Or Use InventoriesForSaleOrUseGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Prepaid Expenses Defrd Charges PrepaidExpensesDefrdChargesGrp

FieldValueIRS element (for citing)
BOY$483,323BOYAmt
EOY$373,197EOYAmt
FieldValueIRS element (for citing)
Land Bldg Equip Cost Or Other Bss$226,556LandBldgEquipCostOrOtherBssAmt
Land Bldg Equip Accum Deprec$206,364LandBldgEquipAccumDeprecAmt

Land Bldg Equip Basis Net LandBldgEquipBasisNetGrp

FieldValueIRS element (for citing)
BOY$29,069BOYAmt
EOY$20,192EOYAmt

Investments Pub Traded Sec InvestmentsPubTradedSecGrp

FieldValueIRS element (for citing)
BOY$4,694,792BOYAmt
EOY$4,826,460EOYAmt

Investments Other Securities InvestmentsOtherSecuritiesGrp

FieldValueIRS element (for citing)
BOY$200,442BOYAmt
EOY$200,442EOYAmt

Investments Program Related InvestmentsProgramRelatedGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Intangible Assets IntangibleAssetsGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Other Assets Total OtherAssetsTotalGrp

FieldValueIRS element (for citing)
BOY$3,275,588BOYAmt
EOY$3,307,913EOYAmt

Total Assets TotalAssetsGrp

FieldValueIRS element (for citing)
BOY$10,719,078BOYAmt
EOY$10,533,674EOYAmt

Accounts Payable Accr Expnss AccountsPayableAccrExpnssGrp

FieldValueIRS element (for citing)
BOY$876,435BOYAmt
EOY$722,035EOYAmt

Grants Payable GrantsPayableGrp

FieldValueIRS element (for citing)
BOY$1,285,132BOYAmt
EOY$1,393,836EOYAmt

Deferred Revenue DeferredRevenueGrp

FieldValueIRS element (for citing)
BOY$135BOYAmt
EOY$135EOYAmt

Tax Exempt Bond Liabilities TaxExemptBondLiabilitiesGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Escrow Account Liability EscrowAccountLiabilityGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Loans From Officers Directors LoansFromOfficersDirectorsGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Mortg Notes Pybl Scrd Invst Prop MortgNotesPyblScrdInvstPropGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Unsecured Notes Loans Payable UnsecuredNotesLoansPayableGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Other Liabilities OtherLiabilitiesGrp

FieldValueIRS element (for citing)
BOY$949,794BOYAmt
EOY$736,957EOYAmt

Total Liabilities TotalLiabilitiesGrp

FieldValueIRS element (for citing)
BOY$3,111,496BOYAmt
EOY$2,852,963EOYAmt
FieldValueIRS element (for citing)
Organization Follows FASB117Yes (X)OrganizationFollowsFASB117Ind

No Donor Restriction Net Assets NoDonorRestrictionNetAssetsGrp

FieldValueIRS element (for citing)
BOY$4,277,731BOYAmt
EOY$4,299,106EOYAmt

Donor Restriction Net Assets DonorRestrictionNetAssetsGrp

FieldValueIRS element (for citing)
BOY$3,329,851BOYAmt
EOY$3,381,605EOYAmt

Total Net Assets Fund Balance TotalNetAssetsFundBalanceGrp

FieldValueIRS element (for citing)
BOY$7,607,582BOYAmt
EOY$7,680,711EOYAmt

Tot Liab Net Assets Fund Balance TotLiabNetAssetsFundBalanceGrp

FieldValueIRS element (for citing)
BOY$10,719,078BOYAmt
EOY$10,533,674EOYAmt
FieldValueIRS element (for citing)
Reconcilation Revenue Expnss-$628,089ReconcilationRevenueExpnssAmt
Net Unrlzd Gains Losses Invst$701,218NetUnrlzdGainsLossesInvstAmt
Method Of Accounting AccrualYes (X)MethodOfAccountingAccrualInd
Accountant Compile Or ReviewfalseAccountantCompileOrReviewInd
FS AuditedYes (true)FSAuditedInd

FS Audited Basis FSAuditedBasisGrp

FieldValueIRS element (for citing)
Consolidated Basis Fincl StmtYes (X)ConsolidatedBasisFinclStmtInd
FieldValueIRS element (for citing)
Audit CommitteeYes (true)AuditCommitteeInd
Federal Grant Audit RequiredfalseFederalGrantAuditRequiredInd

Schedule A IRS990ScheduleA

FieldValueIRS element (for citing)
Public Organization170Yes (X)PublicOrganization170Ind

Gifts Grants Contri Rcvd170 GiftsGrantsContriRcvd170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$9,898,471CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$10,990,906CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$9,444,496CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$8,181,991CurrentTaxYearMinus1YearAmt
Current Tax Year$8,681,414CurrentTaxYearAmt
Total$47,197,278TotalAmt

Tax Rev Levied Orgnztnl Bnft170 TaxRevLeviedOrgnztnlBnft170Grp

FieldValueIRS element (for citing)
Total$0TotalAmt

Govt Furn Srvc Fclts Vl170 GovtFurnSrvcFcltsVl170Grp

FieldValueIRS element (for citing)
Total$0TotalAmt

Total Calendar Year170 TotalCalendarYear170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$9,898,471CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$10,990,906CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$9,444,496CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$8,181,991CurrentTaxYearMinus1YearAmt
Current Tax Year$8,681,414CurrentTaxYearAmt
Total$47,197,278TotalAmt
FieldValueIRS element (for citing)
Substantial Contributors Tot$356,054SubstantialContributorsTotAmt
Public Support Total170$46,841,224PublicSupportTotal170Amt

Gross Investment Income170 GrossInvestmentIncome170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$270,568CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$222,444CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$276,898CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$202,224CurrentTaxYearMinus1YearAmt
Current Tax Year$252,937CurrentTaxYearAmt
Total$1,225,071TotalAmt

Unrelated Business Net Incm170 UnrelatedBusinessNetIncm170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$0CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$0CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$2,859CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$0CurrentTaxYearMinus1YearAmt
Current Tax Year$1,186CurrentTaxYearAmt
Total$4,045TotalAmt

Other Income170 OtherIncome170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$301,733CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$192,317CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$135,298CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$86,699CurrentTaxYearMinus1YearAmt
Current Tax Year$102,377CurrentTaxYearAmt
Total$818,424TotalAmt
FieldValueIRS element (for citing)
Total Support$49,244,818TotalSupportAmt
Public Support CY1700.95119PublicSupportCY170Pct
Public Support PY1700.95008PublicSupportPY170Pct
Thirty Thr Pct Suprt Tests CY170Yes (X)ThirtyThrPctSuprtTestsCY170Ind

Schedule B IRS990ScheduleB

Contributor Information ContributorInformationGrp

FieldValueIRS element (for citing)
ContributorRESTRICTEDContributorNum

Contributor Business Name ContributorBusinessName

FieldValueIRS element (for citing)
Business Name Line1RESTRICTEDBusinessNameLine1

Contributor US Address ContributorUSAddress

FieldValueIRS element (for citing)
Address Line1RESTRICTEDAddressLine1
Address Line2RESTRICTEDAddressLine2
CityRESTRICTEDCity
StateRESTRICTEDState
ZIP CodeRESTRICTEDZIPCode
FieldValueIRS element (for citing)
Total ContributionsRESTRICTEDTotalContributionsAmt

Schedule D IRS990ScheduleD

FieldValueIRS element (for citing)
Donor Advised Funds Held1DonorAdvisedFundsHeldCnt
Donor Advised Funds Vl EOY$3,040DonorAdvisedFundsVlEOYAmt
Disclosed Org Leg CtrlYes (true)DisclosedOrgLegCtrlInd
Disclosed For Charitable PrpsYes (true)DisclosedForCharitablePrpsInd
Art Public Exhibition AmountsArtPublicExhibitionAmountsGrp
Held Works ArtHeldWorksArtGrp

CY Endwmt Fund CYEndwmtFundGrp

FieldValueIRS element (for citing)
Beginning Year Balance$6,205,432BeginningYearBalanceAmt
Contributions$3,405,566ContributionsAmt
Investment Earnings Or Losses$62,641InvestmentEarningsOrLossesAmt
Other Expenditures$3,351,278OtherExpendituresAmt
End Year Balance$6,322,361EndYearBalanceAmt

CY Minus1 Yr Endwmt Fund CYMinus1YrEndwmtFundGrp

FieldValueIRS element (for citing)
Beginning Year Balance$7,190,200BeginningYearBalanceAmt
Contributions$2,206,693ContributionsAmt
Investment Earnings Or Losses-$605,813InvestmentEarningsOrLossesAmt
Other Expenditures$2,585,648OtherExpendituresAmt
End Year Balance$6,205,432EndYearBalanceAmt

CY Minus2 Yr Endwmt Fund CYMinus2YrEndwmtFundGrp

FieldValueIRS element (for citing)
Beginning Year Balance$7,784,738BeginningYearBalanceAmt
Contributions$3,290,006ContributionsAmt
Investment Earnings Or Losses$213,641InvestmentEarningsOrLossesAmt
Other Expenditures$4,098,185OtherExpendituresAmt
End Year Balance$7,190,200EndYearBalanceAmt

CY Minus3 Yr Endwmt Fund CYMinus3YrEndwmtFundGrp

FieldValueIRS element (for citing)
Beginning Year Balance$7,915,837BeginningYearBalanceAmt
Contributions$3,260,266ContributionsAmt
Investment Earnings Or Losses$193,223InvestmentEarningsOrLossesAmt
Other Expenditures$3,584,588OtherExpendituresAmt
End Year Balance$7,784,738EndYearBalanceAmt

CY Minus4 Yr Endwmt Fund CYMinus4YrEndwmtFundGrp

FieldValueIRS element (for citing)
Beginning Year Balance$10,396,983BeginningYearBalanceAmt
Contributions$4,136,982ContributionsAmt
Investment Earnings Or Losses$286,710InvestmentEarningsOrLossesAmt
Other Expenditures$6,904,838OtherExpendituresAmt
End Year Balance$7,915,837EndYearBalanceAmt
FieldValueIRS element (for citing)
Board Designated Balance EOY0.46460BoardDesignatedBalanceEOYPct
Prmnnt Endowment Balance EOY0.35310PrmnntEndowmentBalanceEOYPct
Term Endowment Balance EOY0.18230TermEndowmentBalanceEOYPct
Endowments Held Unrelated OrgfalseEndowmentsHeldUnrelatedOrgInd
Endowments Held Related OrgfalseEndowmentsHeldRelatedOrgInd
LandLandGrp
BuildingsBuildingsGrp

Leasehold Improvements LeaseholdImprovementsGrp

FieldValueIRS element (for citing)
Other Cost Or Other Basis$26,890OtherCostOrOtherBasisAmt
Depreciation$17,678DepreciationAmt
Book Value$9,212BookValueAmt

Equipment EquipmentGrp

FieldValueIRS element (for citing)
Other Cost Or Other Basis$154,284OtherCostOrOtherBasisAmt
Depreciation$146,580DepreciationAmt
Book Value$7,704BookValueAmt

Other Land Buildings OtherLandBuildingsGrp

FieldValueIRS element (for citing)
Other Cost Or Other Basis$45,382OtherCostOrOtherBasisAmt
Depreciation$42,106DepreciationAmt
Book Value$3,276BookValueAmt
FieldValueIRS element (for citing)
Total Book Value Land Buildings$20,192TotalBookValueLandBuildingsAmt

Other Assets Org OtherAssetsOrgGrp (2 entries)

DescDescBook ValueBookValueAmt
AMOUNT HELD IN TRUST BY OTHERS$2,658,016
RIGHT OF USE ASSET$649,897
FieldValueIRS element (for citing)
Total Book Value Other Assets$3,307,913TotalBookValueOtherAssetsAmt
Federal Income Tax Liability$0FederalIncomeTaxLiabilityAmt

Other Liabilities Org OtherLiabilitiesOrgGrp

FieldValueIRS element (for citing)
DescLEASE LIABILITYDesc
Amt$736,957Amt
FieldValueIRS element (for citing)
Total Liability$736,957TotalLiabilityAmt
Footnote TextYes (X)FootnoteTextInd

Supplemental Information Detail SupplementalInformationDetail (2 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
PART V, LINE 4 - INTENDED USE OF ENDOWMENT FUNDS:THE PRINCIPAL ACTIVITIES OF NFCR ARE RAISING FUNDS AND FIGHTING CANCER THROUGH RESEARCH IN PREVENTION, EARLIER DIAGNOSTIC TECHNIQUES, MORE EFFECTIVE TREATMENTS AND ULTIMATELY, ACHIEVING ONE OF MEDICINES GREATEST GOALS: CURING CANCER TO SAVE LIVES. THE FOUNDATION FULFILLS THIS MISSION BY FUNDING ACROSS THE WORLD OUTSTANDING SCIENTISTS THAT PIONEER CANCER RESEARCH AND FUNDING CANCER PREVENTION EDUCATION PROGRAMS. THE DESIGNATED NET ASSETS, TEMPORARILY RESTRICTED NET ASSETS, AND PERMANENTLY RESTRICTED NET ASSETS ALL ARE INTENDED TO PROVIDE FUNDING FOR SUCH RESEARCH AND EDUCATION PROGRAMS.
PART X, LINE 2 - FASB ASC 740 FOOTNOTE:The Foundation has been recognized by the Internal Revenue Service ("IRS") as exempt from income tax under Internal Revenue Code Section 501(c)(3) and related state statutes, except for income tax on unrelated business income, if any. It qualifies as a public charity under Section 509(a)(1). The Darwin Foundation has been recognized by the IRS as exempt from income tax under Section 501 (c)(3) and related state statutes, except for income tax on unrelated business income, if any. It is a supporting organization to NFCR under Section 509(a)(3). NFCR Western Chapter, a California nonprofit corporation, and NFCR Mid-Atlantic Chapter, a District of Columbia nonprofit corporation were added in 2011 by the Foundation to its roster of subordinate organizations covered under the group exemption ruling, dated April 26, 2010, issued by the Internal Revenue Service to the Foundation. Both chapters are exempt from federal and state income tax, except for income tax on unrelated business income, as organizations described under section 501 (c)(3) of the Internal Revenue Code and related state statutes. Accounting principles generally accepted in the United States of America require management to evaluate income tax positions taken and accrue an income tax liability if the organization has taken an uncertain position that more likely than not would not be sustained upon examination by the Internal Revenue Service. Management has evaluated the income tax positions taken and concluded that as of December 31, 2023 there are no uncertain positions taken or expected to be taken that would require recognition in the consolidated financial statements. The Foundation and affiliates are subject to routine audits by taxing jurisdictions, however, there are currently no audits in progress for any tax periods. In addition, there have been no tax related interest or penalties for the periods presented in these consolidated financial statements. Should such penalties and interest be incurred, the Foundation's policy is to recognize them as general and administrative expenses on the consolidated statements of activities.

Schedule F IRS990ScheduleF

FieldValueIRS element (for citing)
Grant Records MaintainedYes (true)GrantRecordsMaintainedInd

Account Activities Outside US AccountActivitiesOutsideUSGrp (3 entries)

RegionRegionTxtOfficesOfficesCntEmployeeEmployeeCntType Of Activities ConductedTypeOfActivitiesConductedTxtRegion Total ExpendituresRegionTotalExpendituresAmt
Europe (Including Iceland and Greenland)00Grantmaking$90,000
Middle East and North Africa00Grantmaking$30,000
East Asia and the Pacific00Grantmaking$5,000
FieldValueIRS element (for citing)
Subtotal Offices0SubtotalOfficesCnt
Subtotal Employees0SubtotalEmployeesCnt
Total Office0TotalOfficeCnt
Total Employee0TotalEmployeeCnt
Subtotal Spent$125,000SubtotalSpentAmt
Total Spent$125,000TotalSpentAmt

Grants To Org Outside US GrantsToOrgOutsideUSGrp

FieldValueIRS element (for citing)
RegionEurope (Including Iceland and Greenland)RegionTxt
Purpose Of GrantResearch ContractsPurposeOfGrantTxt
Cash Grant$85,000CashGrantAmt
Manner Of Cash DisbursementWIREMannerOfCashDisbursementTxt
FieldValueIRS element (for citing)
Total501c3 Org1Total501c3OrgCnt
Total Other Org0TotalOtherOrgCnt

Foreign Individuals Grants ForeignIndividualsGrantsGrp (3 entries)

Type Of AssistanceTypeOfAssistanceTxtRegionRegionTxtRecipientRecipientCntCash GrantCashGrantAmtManner Of Cash DisbursementMannerOfCashDisbursementTxt
AWARD FOR CANCER RESEARCH PROGRESS.Middle East and North Africa1$30,000check
RESEARCH REVIEWEurope (Including Iceland and Greenland)1$5,000check
RESEARCH REVIEWEast Asia and the Pacific1$5,000check
FieldValueIRS element (for citing)
Transfer To Foreign CorpfalseTransferToForeignCorpInd
Interest In Foreign TrustfalseInterestInForeignTrustInd
Foreign Corp OwnershipfalseForeignCorpOwnershipInd
Passive Foreign Investmest CofalsePassiveForeignInvestmestCoInd
Foreign PartnershipfalseForeignPartnershipInd
Boycott CountriesfalseBoycottCountriesInd

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferencePART I, LINE 2FormAndLineReferenceDesc
ExplanationProcedure for monitoring use of grants outside USA: Grant and Contract recipients are required to submit quarterly expenditure reports and annual progress reports to NFCR.ExplanationTxt

Schedule G IRS990ScheduleG

FieldValueIRS element (for citing)
Mail SolicitationsYes (X)MailSolicitationsInd
Email SolicitationsYes (X)EmailSolicitationsInd
Phone SolicitationsYes (X)PhoneSolicitationsInd
In Person SolicitationsYes (X)InPersonSolicitationsInd
Solicitation Of Non Govt GrantsYes (X)SolicitationOfNonGovtGrantsInd
Special Fundraising EventsYes (X)SpecialFundraisingEventsInd
Agrmt Prof Fundraising ActyYes (true)AgrmtProfFundraisingActyInd

Fundraiser Activity Info FundraiserActivityInfoGrp

FieldValueIRS element (for citing)
PersonAMERGENT INCPersonNm

US Address USAddress

FieldValueIRS element (for citing)
Address Line19 CENTENNIAL DRAddressLine1Txt
CityPEABODYCityNm
State AbbreviationMAStateAbbreviationCd
ZIP01960ZIPCd
FieldValueIRS element (for citing)
ActivityCounselActivityTxt
Fundraiser Control Of FundsfalseFundraiserControlOfFundsInd
Gross Receipts$3,567,682GrossReceiptsAmt
Retained By Contractor$31,582RetainedByContractorAmt
Net To Organization$3,536,100NetToOrganizationAmt
FieldValueIRS element (for citing)
Total Gross Receipts$3,567,682TotalGrossReceiptsAmt
Total Retained By Contractors$31,582TotalRetainedByContractorsAmt
Total Net To Organization$3,536,100TotalNetToOrganizationAmt
Licensed StatesALLicensedStatesCd
Licensed StatesAKLicensedStatesCd
Licensed StatesAZLicensedStatesCd
Licensed StatesARLicensedStatesCd
Licensed StatesCALicensedStatesCd
Licensed StatesCOLicensedStatesCd
Licensed StatesCTLicensedStatesCd
Licensed StatesDCLicensedStatesCd
Licensed StatesFLLicensedStatesCd
Licensed StatesGALicensedStatesCd
Licensed StatesHILicensedStatesCd
Licensed StatesILLicensedStatesCd
Licensed StatesINLicensedStatesCd
Licensed StatesKSLicensedStatesCd
Licensed StatesKYLicensedStatesCd
Licensed StatesMELicensedStatesCd
Licensed StatesMDLicensedStatesCd
Licensed StatesMALicensedStatesCd
Licensed StatesMILicensedStatesCd
Licensed StatesMNLicensedStatesCd
Licensed StatesMOLicensedStatesCd
Licensed StatesNHLicensedStatesCd
Licensed StatesNJLicensedStatesCd
Licensed StatesNMLicensedStatesCd
Licensed StatesNYLicensedStatesCd
Licensed StatesNCLicensedStatesCd
Licensed StatesNDLicensedStatesCd
Licensed StatesOHLicensedStatesCd
Licensed StatesOKLicensedStatesCd
Licensed StatesORLicensedStatesCd
Licensed StatesPALicensedStatesCd
Licensed StatesRILicensedStatesCd
Licensed StatesSCLicensedStatesCd
Licensed StatesTNLicensedStatesCd
Licensed StatesUTLicensedStatesCd
Licensed StatesVALicensedStatesCd
Licensed StatesWALicensedStatesCd
Licensed StatesWVLicensedStatesCd
Licensed StatesWYLicensedStatesCd

Fundraising Event Information FundraisingEventInformationGrp

FieldValueIRS element (for citing)
Event1PLAY FOR A CUREEvent1Nm
Gross Receipts Event1$158,624GrossReceiptsEvent1Amt
Charitable Contri Event1$158,624CharitableContriEvent1Amt
Other Direct Expenses Event1$4,125OtherDirectExpensesEvent1Amt
Event2DAFFODILS & DIAEvent2Nm
Gross Receipts Event2$115,973GrossReceiptsEvent2Amt
Charitable Contri Event2$70,000CharitableContriEvent2Amt
Gross Revenue Event2$45,973GrossRevenueEvent2Amt
Rent Facility Costs Event2$10,000RentFacilityCostsEvent2Amt
Food And Beverage Event2$11,845FoodAndBeverageEvent2Amt
Other Direct Expenses Event2$8,726OtherDirectExpensesEvent2Amt
Other Events Total2OtherEventsTotalCnt
Gross Receipts Other Events$60,533GrossReceiptsOtherEventsAmt
Charitable Contri Other Events$60,533CharitableContriOtherEventsAmt
Oth Direct Expnss Other Events$10,091OthDirectExpnssOtherEventsAmt
Gross Receipts Total$335,130GrossReceiptsTotalAmt
Charitable Contributions Tot$289,157CharitableContributionsTotAmt
Gross Revenue Total Events$45,973GrossRevenueTotalEventsAmt
Rent Fclty Costs Total Events$10,000RentFcltyCostsTotalEventsAmt
Food And Beverage Total Events$11,845FoodAndBeverageTotalEventsAmt
Oth Direct Expnss Total Events$22,942OthDirectExpnssTotalEventsAmt
Direct Expense Summary Events$44,787DirectExpenseSummaryEventsAmt
Net Income Summary$1,186NetIncomeSummaryAmt

Schedule I IRS990ScheduleI

FieldValueIRS element (for citing)
Grant Records MaintainedYes (true)GrantRecordsMaintainedInd

Recipient Table RecipientTable (20 entries)

Address Line1USAddress/AddressLine1TxtCityUSAddress/CityNmState AbbreviationUSAddress/StateAbbreviationCdZIPUSAddress/ZIPCdRecipient EINRecipientEINIRC SectionIRCSectionDescCash GrantCashGrantAmtPurpose Of GrantPurposeOfGrantTxtAddress Line2USAddress/AddressLine2Txt
CASE WESTERN RESERVE UNIVERSITY
10900 EUCLID AVENUECLEVELANDOH44106341018992501(c)(3)$65,731RESEARCH CONTRACTS
DANA-FARBER CANCER INSTITUTE
44 BINNEY STBOSTONMA02115042263040501(c)(3)$220,041RESEARCH CONTRACTSMAIL STOP L229
UNIVERSITY OF CALIFORNIA AT SAN DIEGO
PO BOX 12385LA JOLLACA92093943067788501(c)(3)$52,044RESEARCH CONTRACTS
YALE UNIVERSITY
PO BOX 1873NEW HAVENCT06508060646973501(c)(3)$130,000RESEARCH CONTRACTS
KUMC RESEARCH INSTITUTE INC
3901 RAINBOW BLVDKANSAS CITYKS66103481108830501(c)(3)$87,282RESEARCH CONTRACTSMAIL STOP 1039
WEILL CORNELL MEDICAL COLLEGE
1300 YORK AVENUENEW YORKNY10065150532082501(c)(3)$85,000RESEARCH CONTRACTSBOX 164
UNIVERSITY OF PENNSYLVANIA
3451 WALNUT STPHILADELPHIAPA19104231352685501(C)(3)$123,272RESEARCH CONTRACTS
AIM HI ACCELERATOR FUND
5515 SECURITY LN 1105ROCKVILLEMD20852824322538501(C)(3)$850,000collaboration
MASSACHUSETTS GENERAL HOSPITAL
P O BOX 414876BOSTONMA02241041564655501(C)(3)$268,242RESEARCH CONTRACTS
OREGON HEALTH AND SCIENCE UNIVERSITY
3181 SW SAM JACKSON PARK RDPORTLANDOR97239237083114501(C)(3)$128,326RESEARCH CONTRACTS
JOHNS HOPKINS UNIVERSITY
3400 N CHARLES STBALTIMOREMD21218520595110501(C)(3)$108,670RESEARCH CONTRACTS
UNIVERSITY OF WASHINGTON
509 OLIVE WAYSEATTLEWA98101916001537501(C)(3)$33,633RESEARCH CONTRACTS
NEW YORK UNIVERSITY GROSSMAN SCHOOL MED
1 PARK AVE 6TH FLOORNEW YORKNY10016135562308501(C)(3)$88,675RESEARCH CONTRACTS
UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CTR
660 PARRINGTON OVAL RM 119NORMANOK73019736091755501(C)(3)$30,888RESEARCH CONTRACTS
Parthen Inst of Transformative Oncology
5515 Security LaneRockvilleMD20852923224051501(C)(3)$30,000Research Contracts
Ovarian Cancer Research Alliance
14 Pennsylvania PlazaNew YorkNY10122133806788501(C)(3)$500,000Research Grant
Henry Ford Health System
2799 West Grand BlvdDetroitMI48202381357020501(C)(3)$85,000Research Contracts
Icahn School of Medicine at Mount Sinai
1 Gustave L Levy PlaceNew YorkNY10029136171197501(C)(3)$85,000Research Contracts
Umass Chan Medical School
333 South StreetShrewsburyMA01545043108190501(C)(3)$85,000Research Contracts
UT Southwestern Medical Center
5323 Harry Hines BlvdDallasTX75390750945939501(C)(3)$85,000Research Contracts
FieldValueIRS element (for citing)
Total501c3 Org20Total501c3OrgCnt
Total Other Org0TotalOtherOrgCnt

Grants Other Asst To Indiv In US GrantsOtherAsstToIndivInUSGrp (2 entries)

Grant TypeGrantTypeTxtRecipientRecipientCntCash GrantCashGrantAmt
CANCER RESEARCH3$149,159
RESEARCH REVIEW2$55,000

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferencePART I, LINE 2 - PROCEDURES FOR MONITORING USE OF GRANT FUNDS IN USA:FormAndLineReferenceDesc
ExplanationGRANT AND CONTRACT RECIPIENTS ARE REQUIRED TO SUBMIT QUARTERLY EXPENDITURE REPORTS AND ANNUAL PROGRESS REPORTS TO NFCR.ExplanationTxt

Schedule J IRS990ScheduleJ

FieldValueIRS element (for citing)
Compensation CommitteeYes (X)CompensationCommitteeInd
Independent ConsultantYes (X)IndependentConsultantInd
Form990 Of Other OrganizationsYes (X)Form990OfOtherOrganizationsInd
Written Employment ContractYes (X)WrittenEmploymentContractInd
Compensation SurveyYes (X)CompensationSurveyInd
Board Or Committee ApprovalYes (X)BoardOrCommitteeApprovalInd
Severance PaymentfalseSeverancePaymentInd
Supplemental Nonqual Rtr PlanfalseSupplementalNonqualRtrPlanInd
Equity Based Comp ArrngmfalseEquityBasedCompArrngmInd
Comp Based On Revenue Of Flng OrgfalseCompBasedOnRevenueOfFlngOrgInd
Comp Bsd On Rev Related OrgsfalseCompBsdOnRevRelatedOrgsInd
Comp Bsd Net Earns Flng OrgfalseCompBsdNetEarnsFlngOrgInd
Comp Bsd Net Earns Rltd OrgsfalseCompBsdNetEarnsRltdOrgsInd
Any Non Fixed PaymentsYes (true)AnyNonFixedPaymentsInd
Initial Contract ExceptionfalseInitialContractExceptionInd

Rltd Org Officer Trst Key Empl RltdOrgOfficerTrstKeyEmplGrp (3 entries)

TitleTitleTxtBase Compensation Filing OrgBaseCompensationFilingOrgAmtCompensation Based On Rltd OrgsCompensationBasedOnRltdOrgsAmtBonus Filing OrganizationBonusFilingOrganizationAmountBonus Related OrganizationsBonusRelatedOrganizationsAmtOther Compensation Filing OrgOtherCompensationFilingOrgAmtOther Compensation Rltd OrgsOtherCompensationRltdOrgsAmtDeferred Compensation Flng OrgDeferredCompensationFlngOrgAmtDeferred Comp Rltd OrgsDeferredCompRltdOrgsAmtNontaxable Benefits Filing OrgNontaxableBenefitsFilingOrgAmtNontaxable Benefits Rltd OrgsNontaxableBenefitsRltdOrgsAmtTotal Compensation Filing OrgTotalCompensationFilingOrgAmtTotal Compensation Rltd OrgsTotalCompensationRltdOrgsAmtComp Report Prior990 Filing OrgCompReportPrior990FilingOrgAmtComp Report Prior990 Rltd OrgsCompReportPrior990RltdOrgsAmt
SUJUAN BA
PRESIDENT/CEO$445,197$0$25,000$0$1,188$0$58,576$0$23,349$0$553,310$0$0$0
KWOK LEUNG
CFO/SECRETARY$202,891$0$0$0$1,188$0$30,434$0$0$0$234,513$0$0$0
BRIAN WACHTEL
EXECUTIVE DIRECTOR$144,838$0$6,000$0$270$0$17,381$0$0$0$168,489$0$0$0

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferenceSCHEDULE J, PART I, LINE 7FormAndLineReferenceDesc
ExplanationBONUSES PAID TO KWOK LEUNG, BRIAN WACHTEL, AND ZETING WANG ARE DETERMINED ON AN ANNUAL BASIS BY THE BOARD AND/OR MANAGEMENT OF NFCR. RETENTION BONUS PAID TO SUJUAN BA IS DETERMINED BY THE BOARD ON HER EMPLOYMENT CONTRACT.ExplanationTxt

Schedule O IRS990ScheduleO

Supplemental Information Detail SupplementalInformationDetail (8 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
PART III, LINE 1 - ORGANIZATION'S MISSION:The National Foundation for Cancer Research (NFCR) is a leading public charity dedicated to funding cancer research and public education relating to cancer prevention, earlier diagnosis, better treatments and, ultimately, cures for cancer. NFCR has distinguished itself in the cancer research sector by emphasizing long-term, transformative research often overlooked by other major funding sources. NFCR promotes and facilitates collaboration among scientists to accelerate the pace of discovery from bench to bedside. Since 1973, NFCR has provided more than $415 million in support of discovery-oriented cancer research focused on understanding how and why cells become cancerous, and on public education relating to cancer prevention, detection, and treatment. NFCR is committed to fighting cancer by funding high-risk, high-impact, and potentially high-reward discoveries in the labs and transforming them into life-saving treatments for cancer patients. Through global collaboration, NFCR is making unique impacts on new, accelerated paths to a cure. NFCR envisions a world without cancer!
PART III, LINE 4A - CANCER RESEARCH PROGRM ACCOMPLISHMENTS:HIGHLIGHTS OF RESEARCH ACCOMPLISHMENTS ---------------------------------------------- With support from our generous donors, NFCR-funded scientists have made numerous remarkable advances in the fight against cancer. Their research encompasses a wide variety of fields, many of which could ultimately lead to a cure for this deadly disease. CHROMOSOME LOSS & IMMUNE RESISTANCE ------------------------------------ TERESA DAVOLI, PH.D. PREVIOUSLY SHOWED LOSS OF A SPECIFIC "P" REGION OF CHROMOSOME 9P IS MORE FREQUENT IN PATIENTS NOT RESPONDING TO IMMUNOTHERAPY. TO UNDERSTAND THE MECHANISM, HER TEAM USED CRSIPR GENE-EDITING TOOL TO MODIFY HUMAN CANCER CELL LINES TO CONTAIN THE LOSS OF REGIONS ON CHROMOSOME 9P. COMPUTATIONAL ANALYSIS DECIPHERED WHICH 9P GENES ARE CRITICAL FOR IMMUNE EVASION. IN LAB MODELS, SILVIO GUTKIND, PH.D. IS DISSECTING WHY TUMORS WITH 9P LOSS RESPOND LESS TO IMMUNOTHERAPY. THIS RESEARCH IS ENLIGHTENING HOW TUMOR CELLS EVADE THE IMMUNE SYSTEMS' RECOGNITION AND ATTACK. 9P LOSS IS A COMMON FEATURE OF SOLID TUMORS, ESPECIALLY MELANOMA AND ORAL, LUNG, AND BLADDER CANCERS. THIS RESEARCH MAY POTENTIALLY HELP IDENTIFY PATIENTS WHO WILL RESPOND TO IMMUNOTHERAPY AND IMPROVE CURRENT IMMUNOTHERAPEUTIC STRATEGIES. COMBATTING BRAIN METASTASIS IN BREAST AND OTHER CANCER -------------------------------------------------------- HER2-POSITIVE BREAST TUMORS (ABNORMAL AMOUNTS OF HER2 GROWTH PROTEIN) ARE TREATED WITH TARGETED THERAPIES BUT SOME PATIENTS DO NOT RESPOND TO TREATMENT AND DEVELOP BRAIN METASTASES WITH DISMAL OUTCOMES. KORNELIA POLYAK, M.D., PH.D. AND VALERIE WEAVER, PH.D. ARE EXPLORING HOW THE BRAIN ENVIRONMENT ENABLES BREAST CANCER CELLS TO GROW AND SURVIVE. THEIR RESULTS OPEN A NEW AND SIGNIFICANT RESEARCH FIELD. THE DATA SUGGEST THAT TARGETING SUGAR MOLECULES OR GLYCOSYLATION IN CELLS AND THE SPECIFIC INTERACTIONS BETWEEN BRAIN CELLS AND CANCER CELLS COULD IMPROVE THE OUTCOMES OF BREAST CANCER PATIENTS WITH BRAIN METASTASES. MOREOVER, THESE RESULTS ARE RELEVANT TO OTHER CANCER TYPES THAT COMMONLY METASTASIZE TO THE BRAIN INCLUDING MELANOMA AND LUNG CANCER. IMMUNOTHERAPY FOR MERKLE CELL CANCER AND OTHER VIRUS-DRIVEN CANCERS. -------------------------------------------------------------------- WHILE 50% OF PATIENTS WITH MERKEL CELL CANCER (MCC) RESPOND WELL TO IMMUNE-BASED THERAPIES, OTHERS DO NOT. AS WITH MOST CANCERS, THE BASIS FOR DIFFERENT OUTCOMES IS UNKNOWN. MERKEL CELL POLYOMAVIRUS CAUSES 80% OF MCCS WHILE 20% IS CAUSED BY UV LIGHT-INDUCED DNA MUTATIONS. EACH MCC SUBTYPE MAY BE 'SEEN' IN DIFFERENT WAYS BY THE IMMUNE SYSTEM. DRS. SUZANNE TOPALIAN AND PAUL NGHEIM ARE STUDYING GENE EXPRESSION IN TUMOR- INFILTRATING T CELLS IN PATIENTS RECEIVING IMMUNOTHERAPY. COMPUTER MODELING REVEALED A GENE EXPRESSION PROFILE DERIVED FROM LUNG CANCER MUTATION-SPECIFIC T CELLS ALSO IDENTIFIES TUMOR- SPECIFIC T CELLS IN MCC SPECIMENS. A DEEPER UNDERSTANDING OF IMMUNE CELL-TYPES IN TUMORS RESPONDING OR NOT TO IMMUNOTHERAPY IS NOW POSSIBLE. THIS RESEARCH WILL ALLOW COMBINATIONS OF EXISTING AND EMERGING THERAPIES TO HELP PATIENTS OVERCOME MCC AND OTHER VIRUS-DRIVEN CANCERS. PAIRING LUNG CANCER PATIENTS WITH THE RIGHT TREATMENT ------------------------------------------------------------------------ LUNG CANCER PATIENTS WITH MUTATIONS IN THE ALK GENE (OR ALK-POSITIVE OR ALK+) EVENTUALLY BECOME RESISTANT TO THE 1ST, 2ND, AND 3RD LINE OF STANDARD THERAPIES WITH NO OTHER AVAILABLE LIFE-SUSTAINING THERAPY. AARON HATA, M.D., PH.D. AND JESSICA LIN, M.D. ARE USING A NEW BREAKTHROUGH TECHNOLOGY THAT IDENTIFIES AND QUANTIFIES THE GENES IN PRESERVED BIOPSY SAMPLES, A METHOD NOT PREVIOUSLY POSSIBLE. A DEEPER UNDERSTANDING OF HOW CANCERS CHANGE WITH TARGETED THERAPIES CAN POTENTIALLY NOMINATE NEW WAYS TO TREAT RESISTANT CANCERS AND SAVE LIVES. Predicting Why Cancer Spreads in Some Patients ------------------------------------------------ DANNY WELCH, PH.D. AND ISIDORE RIGOUTSOS, PH.D. ARE FINDING VARIABILITIES IN A SHORT FORM OF RNA IN THE MITOCHONDRIA, THE CELL PART THAT PRODUCES OUR BODY'S ENERGY, POSSIBLY EXPLAINING WHY CANCER SPREADS IN SOME PATIENTS BUT NOT IN OTHERS. THE RNA MAY PARTIALLY EXPLAIN RACIAL DISPARITIES IN CANCER RATES AND SEVERITY. THEIR RESEARCH SUGGESTS THAT A SIMPLE BLOOD TEST COULD GUIDE DOCTORS TO AGGRESSIVELY TREAT PATIENTS WHOSE CANCER MAY SPREAD OR SPARE PATIENTS AT LOW RISK FROM UNDERGOING TREATMENTS WITH HARSH SIDE EFFECTS. CAR-T Cell Immunotherapy for Pancreatic Cancer ----------------------------------------------- THERE ARE NO EFFECTIVE CAR-T CELL THERAPIES (OR T CELL-BASED IMMUNOTHERAPIES) FOR PANCREATIC CANCER. AVERY POSEY, PH.D. AND COURTNEY HOUCHEN, M.D. ARE DEVELOPING CAR-T CELLS THAT TARGET TWO TUMOR-ASSOCIATED PROTEINS CONTRIBUTING TO IMMUNE SUPPRESSION. THIS APPROACH MAY ENHANCE THE ANTI-TUMOR EFFICACY OF THESE CAR-T CELLS AND PREVENT TUMOR ESCAPE. THIS WORK IS IDENTIFYING THE MOST PROMISING CANDIDATES FOR FUTURE CLINICAL STUDIES - GIVING PANCREATIC PATIENTS HOPE FOR A NEW TREATMENT. NEW FOCUS: Early Detection & Intervention ------------------------------------------- A new NFCR focuses on early cancer detection, early-stage cancer intervention, and treatment. We are supporting a group of leading-edge scientists pioneering and investigating innovative approaches to stop cancers at their early stage, such as stage zero, and to detect them before new cancer happens. Dr. Azra Raza, a distinguished trailblazer, particularly in hematology and oncology, seeks to identify elusive biomarkers that serve as harbingers of cancer, allowing for timely intervention when the disease is most amenable to treatment. Her work has shed light on the role of abnormally large cells in cancer development and progression. It has opened new avenues for therapeutic interventions and diagnostic strategies in the battle against cancer. Dr. Siddhartha Mukherjee's research focuses on the microenvironment in the bone marrow where bone-stem cells signal and regulate the development of blood stem cells. By unraveling these key signals, he aims to identify changes that might signal dangerous blood cancers like myelodysplastic syndrome and leukemia at an earlier stage. By developing and improving screening tests to find and diagnose cancer at its earliest, most treatable stages, scientists are working to reduce overall cancer risk and prevent the disease from developing. We will kill cancers before they kill people. Our goal is to reduce cancer incidences and increase cancer survivors. New Research Program: Expanding Powerful Detection Technology for Many Cancers ----------------------------------------------------------------------- ADVANCED AND METASTATIC CANCER TAKES THE LIVES OF MORE THAN 90% OF PATIENTS. EARLY DETECTION OF CANCER AND ITS PROGRESSION IS A DIRE UNMET NEED FOR PATIENTS, FAMILIES, AND THE CANCER RESEARCH COMMUNITY. NFCR'S NEW INITIATIVE FOCUSES ON CANCER CELL DIAGNOSTIC TECHNOLOGY TO PROVIDE AN INCREASED UNDERSTANDING OF LIVE CANCER CELLS OR CIRCULATING TUMOR CELLS (CTCS) IN REAL-TIME AND AN INCLUSIVE UNDERSTANDING OF THE TUMOR MICROENVIRONMENT AT THE CELLULAR, GENOMIC, TRANSCRIPTOMIC, AND PROTEOMIC LEVELS. TEN LEADING RESEARCHERS FROM ACROSS THE GLOBE HAVE BEGUN TO GENERATE THE KNOWLEDGE NEEDED TO ACCELERATE THIS MOST CRITICAL CANCER PROBLEM FOR CANCER PATIENTS OF EARLY DETECTION AND MONITORING OF ADVANCED CANCER. Botanical Drug Treating Patients in Clinical Trials ----------------------------------------------------- Over two decades of funding from NFCR supporters helped Yung-Chi Cheng, Ph.D. and his team develop YIV-906, a botanical drug with holistic and multiple system anti-cancer properties that enhance immunotherapy and chemotherapy. NFCR's AIM-HI Translational Research Initiative support facilitated the translation of YIV-906 to reach the clinical stages. Now, a phase I/ii global clinical trial is treating liver cancer patients with YIV-906 combined with a frontline drug. Since YIV-906 also protects the gastrointestinal tract from harsh side effects of many therapies, the botanical should alleviate adverse effects of the frontline drug that has caused many patients to discontinue its use. Preliminary trends of phase i/ii trial results look promising for extending progression free survival, overall survival, quality of life and tolerability. With success in final phase clinical trials, YIV-906 could become the first U.S.-approved botanical cancer drug - a remarkable achievement. Unique Clinical Trial Gives Hope to Brain Cancer Patients ---------------------------------------------------------- A revolutionary clinical trial model, GBM AGILE, is now available to treat patients with the deadliest brain cancer, glioblastoma (GBM). Patients who have not had a new effective treatment in decades, now have hope for survival. GBM AGILE's unique design surpasses standard trials to efficiently evaluate multiple new drugs and drug combinations simultaneously. Benefits include lower cost, reduced time, and fewer patients required to
PART III, LINE 4B - CANCER PREVENTION EDUCATION TO THE PUBLIC:NFCR provides the public with free materials containing valuable information on the most up-to-date cancer preventive measures, treatment options, and diagnostic tools. Our powerful message has been mailed annually to households, reaching over 235,000 email subscribers and tens of thousands of individuals through our social media channels (Twitter and Facebook) and through our website and blogs, helps to assure that fewer of today's healthy individuals will get cancer and more of today's cancer patients will become tomorrow's cancer survivors. Our public education materials include early cancer detection guide, cancer prevention kits, recipes for healthy living, electronic and printed newsletters, the latest cancer headlines, and in-depth online cancer information.
PART VI, SECTION B, LINE 11B - REVIEW PROCESS OF FORM 990:THE NATIONAL FOUNDATION FOR CANCER RESEARCH'S PROCESS FOR REVIEWING THE FORM 990. ======================================================================== 1. FORM 990 WILL BE PREPARED AFTER ANNUAL AUDIT IS DONE. 2. THE FIRST DRAFT WILL BE REVIEWED BY THE CHIEF OPERATING OFFICER AND THE CHIEF FINANCIAL OFFICER. 3. AFTER RESOLVING ANY QUESTIONS OR UPDATES, THE REVISED DRAFT WILL BE SENT TO BOARD MEMBERS, PREFERABLY ELECTRONICALLY FOR THEIR REVIEW AND COMMENTS. 4. THE BOARD MEMBER'S COMMENTS, IF ANY, WILL BE INCORPORATED IN THE FINAL RETURN. 5. THE RETURN WILL BE FILED WITH THE IRS PRIOR TO THE DESIGNATED DUE DATE OR EXTENDED DUE DATE. 6. THE STATE VERSION WILL BE PROVIDED TO STATES FOR REGISTRATION RENEWALS AND THE PUBLIC PORTIONS OF THE RETURN WILL BE POSTED ON THE FOUNDATION'S WEBSITE. 7. IN THE OCCASION THAT THERE IS INSUFFIENT TIME PRIOR TO FILING FORM 990 TO SHARE IT WITH THE BOARD, OR THERE IS ABSENCE OF AN OPPORTUNITY FOR ANY MEANINGFUL REVIEW OF FORM 990 BY THE BOARD PRIOR TO THE FILINGS DEADLINE, AN ELECTRONIC VERSION OF THE FILED RETURN WILL BE AVAILABLE FOR BOARD MEMBERS' REVIEW AND COMMENTS AFTER SUBMISSION OF RETURN TO IRS. AN AMENDED RETURN, IF NECESSARY, WILL BE FILED.
PART VI, SECTION B, LINE 12C - CONFLICT OF INTEREST POLICY COMPLIANCE:EACH DIRECTOR, PRIOR TO TAKING HIS/HER POSITION ON THE BOARD, AND ALL PRESENT DIRECTORS SHALL SUBMIT IN WRITING TO THE CHAIRMAN OF THE BOARD A LIST OF ALL BUSINESSES OR OTHER ORGANIZATIONS OF WHICH HE/SHE IS AN OFFICER, DIRECTOR, TRUSTEE, MEMBER, OWNER SHAREHOLDER, EMPLOYEE OR AGENT, WITH WHICH THE FOUNDATION HAS, OR MIGHT REASONABLE IN THE FUTURE ENTER INTO, A RELATIONSHIP OR A TRANSACTION IN WHICH THE DIRECTOR WOULD HAVE CONFLICTING INTEREST ANNUALLY.
PART VI, SECTION B, LINE 15A/15B - OFFICERS COMPENSATION:ON AN ANNUAL BASIS, THE BOARD WILL PERFORM A THOROUGH REVIEW TO DETERMINE SUITABLE COMPENSATION. THIS PROCESS INCLUDES ALL OF THE FOLLOWING THREE ELEMENTS. ======================================================================= 1. REVIEW AND APPROVAL BY BOARD OF DIRECTORS: THE COMPENSATION OF EACH OFFICER IS REVIEWED AND APPROVED BY THE BOARD OF DIRECTORS, PROVIDED THAT PERSONS WITH CONFLICTS OF INTEREST WITH RESPECT TO THE COMPENSATION ARRANGEMENT AT ISSUE ARE NOT INVOLVED IN THIS REVIEW AND APPROVAL. EACH OFFICER'S PERFORMANCE IS EVALUATED BASED ON HIS OR HER JOB RESPONSIBILITIES, AND INTERNAL AND EXTERNAL GOALS SET IN THE PREVIOUS YEAR. 2. REVIEW OF "COMPARABLE COMPENSATION" DATA: THE COMPENSATION OF EACH OFFICER IS REVIEWED AND APPROVED USING DATA AS TO COMPARABLE COMPENSATION FOR SIMILARLY QUALIFIED PERSONS IN FUNCTIONALLY COMPARABLE POSITIONS AT SIMILARLY SITUATED ORGANIZATIONS. COMPARABLE DATA ARE COMPILED BY THE FOUNDATION'S CHIEF FINANCIAL OFFICER AND/OR BY OUTSIDE COMPENSATION CONSULTANTS. COMPARABILITY DATA CAN INCLUDE COMPENSATION DATA FROM IRS FORM 990'S OF SIMILAR ORGANIZATIONS, PUBLISHED COMPENSATION SURVEYS, STUDIES AND GUIDES, AND OTHER SOURCES DEEMED APPROPRIATE AT THE TIME. 3. DOCUMENTATION AND RECORDKEEEPING: THERE IS CONTEMPORANEOUS DOCUMENTATION AND RECORDKEEPING WITH RESPECT TO THE DELIBERATIONS AND DECISIONS REGARDING THE COMPENSATION AGREEMENT. THE RECORD IS KEPT BY THE SECRETARY OF THE FOUNDATION.
PART VI, SECTION C, LINE 19-AVAILABILTY OF DOCUMENTS, POLICIES, AND F/S:THE FOUNDATION MAKES ITS GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND FINANCIAL STATEMENTS AVAILABLE TO THE PUBLIC UPON REQUEST. THE FINANCIAL STATEMENTS ARE ALSO AVAILABLE ON THE FOUNDATION'S WEBSITE.
PART IX, LINE 26, JOINT COSTS ALLOCATION:NFCR IS COMMITTED TO EFFICIENCY AND TRANSPARENCY. FOR MORE THAN 50 YEARS, NFCR HAS BEEN COMMUNICATING WITH SUPPORTERS, DONORS, AND PROSPECTIVE DONORS BY POSTAL MAIL, EMAIL, PHONE, WEBSITE AND OTHER MEANS, BOTH TO REQUEST CONTRIBUTIONS AND TO EDUCATE THE PUBLIC, THEREBY UPHOLDING NFCR'S MISSION STATEMENT ABOUT CANCER AND UPHOLD ITS MISSION, AND AT THE SAME TIME TO PROVIDE FUNDRAISING OPPORTUNITIES. THE COSTS RELATED TO THESE JOINT ACTIVITIES ARE ALLOCATED, THEREBY UPHOLDING NFCR'S MISSION STATEMENT (TO SUPPORT CANCER RESEARCH AND PUBLIC EDUCATION RELATING TO THE PREVENTION, EARLY DIAGNOSIS, BETTER TREATMENTS AND ULTIMATELY, A CURE FOR CANCER). THESE FREE PUBLICATIONS ARE SENT TO TENS OF MILLIONS OF FAMILIES AND INCLUDE MATERIALS SUCH AS EARLY DETECTION GUIDES, CHILDHOOD CANCER CHARTS, CANCER PREVENTION KITS AND RECIPES FOR HEALTHY LIVING. AS A RESULT, IN ACCORDANCE WITH THE FINANCIAL ACCOUNTING STANDARDS BOARD (FASB) GUIDELINES SOP 98-2 (ASC 958-720), WE ALLOCATE A PORTION OF OUR DIRECT MAIL COST TO PROGRAM SERVICES AND TO FUNDRAISING.

Schedule R IRS990ScheduleR

Id Related Tax Exempt Org IdRelatedTaxExemptOrgGrp

Disregarded Entity Name DisregardedEntityName

FieldValueIRS element (for citing)
Business Name Line1DARWIN FOUNDATIONBusinessNameLine1Txt

US Address USAddress

FieldValueIRS element (for citing)
Address Line15515 SECURITY LANE SUITE 1105AddressLine1Txt
CityROCKVILLECityNm
State AbbreviationMDStateAbbreviationCd
ZIP20852ZIPCd
FieldValueIRS element (for citing)
EIN371473821EIN
Primary ActivitiesCANCER RSRCHPrimaryActivitiesTxt
Legal Domicile StateDCLegalDomicileStateCd
Exempt Code Section501(C)3ExemptCodeSectionTxt
Public Charity Status509(A)(3)PublicCharityStatusTxt

Direct Controlling Entity Name DirectControllingEntityName

FieldValueIRS element (for citing)
Business Name Line1NFCRBusinessNameLine1Txt
FieldValueIRS element (for citing)
Controlled OrganizationYes (true)ControlledOrganizationInd
FieldValueIRS element (for citing)
Receipt Of Int Annts Rnts RyltsfalseReceiptOfIntAnntsRntsRyltsInd
Gift Grnt Or Cap Contri To Oth OrgfalseGiftGrntOrCapContriToOthOrgInd
Gift Grnt Cap Contri From Oth OrgfalseGiftGrntCapContriFromOthOrgInd
Loans Or Guarantees To Other OrgfalseLoansOrGuaranteesToOtherOrgInd
Loans Or Guarantees From Oth OrgfalseLoansOrGuaranteesFromOthOrgInd
Div Related OrganizationfalseDivRelatedOrganizationInd
Asset Sale To Other OrgfalseAssetSaleToOtherOrgInd
Asset Purchase From Other OrgfalseAssetPurchaseFromOtherOrgInd
Asset ExchangefalseAssetExchangeInd
Rental Of Facilities To Oth OrgfalseRentalOfFacilitiesToOthOrgInd
Rental Of Fclts From Oth OrgfalseRentalOfFcltsFromOthOrgInd
Perform Of Services For Oth OrgfalsePerformOfServicesForOthOrgInd
Perform Of Services By Other OrgfalsePerformOfServicesByOtherOrgInd
Sharing Of FacilitiesfalseSharingOfFacilitiesInd
Paid Employees SharingfalsePaidEmployeesSharingInd
Reimbursement Paid To Other OrgfalseReimbursementPaidToOtherOrgInd
Reimbursement Paid By Other OrgfalseReimbursementPaidByOtherOrgInd
Transfer To Other OrgfalseTransferToOtherOrgInd
Transfer From Other OrgfalseTransferFromOtherOrgInd